Jiangsu Kanion Pharmaceutical is a Large-scale Traditional Chinese Medicine Enterprise that focuses on researching, manufacturing, and marketing. Domestic, Kanion is a national key high-tech enterprise, a national model enterprise for technology innovation, and ranked Top 100 in the Chinese Pharmaceutical Industry,5th of the Top 10 Chinese Medicine Enterprises, and Top 20 Innovative Pharmaceutical Companies. Until now, the number of employees has been over 5,000.

Kanion had a National Key Laboratory of TCM Pharmaceutical Process Control and Intelligent Manufacturing Technology, National Local Joint Engineering Research Centre for Intelligent Manufacturing Technology of Proprietary Chinese Medicines, etc. national research platform. The research laboratory rewarded the National Key Laboratory of Excellent Enterprise in 2018， which is No.1 in the whole field of medicine.

Kanion has 56 national innovative TCM, over 600 invention patents, and has undertaken more than 40 scientific and technological programs. Awarded one 2nd prize for national technological invention, three 2nd prizes for national, and ten 1st prizes for provincial and ministerial scientific and technological improvement, Kanion has been ranked as the first in the list of China TCM R&D Strength Ranking over the years.GUIZHIFULING has completed Phase Ⅱ clinical trials in the United States and is a model TCM product of Chinese medicine internationalization.

Adhering to the mission of revitalizing traditional Chinese medicine and serving our motherland, Kanion has formed an innovative development model that takes Chinese medicine as the primary line and develops chemical medicine, biological medicine as branches during the 40 years of development, and simultaneously promoting quality enhancement and scale expansion of health industry. To improve the core competitiveness comprehensively.